CEO: Douglas M. Fambrough

Sector: Healthcare
Industry:Biotechnology

Exchange: Nasdaq Global Select

Country: USA

Description: Dicerna Pharmaceuticals Inc is a biopharmaceutical company. It develops ribonucleic acid interference-based pharmaceuticals for treating diseases involving liver, including rare, chronic liver, cardiovascular and viral infections.


Key numbers

Market Capitalization:1829160630
Shares Outstanding: 68431000
Float: 55273156
Next Earning Date:2020-03-25
TTm EPS: -1.4767
TTm Dividend Rate:
200 days moving average:15.19
50 days moving average: 19.4
One day percent Change: 2.77



2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,